PureTech Health plc SEC filings PTCHF
PureTech Health plc has 134 filings in SEC EDGAR's recent list, going back to Sep 22, 2020. Its latest annual report, Form 20-F, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on May 1, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| F-6 POS | Filing | May 22, 2026 | — |
| 424B3 | Prospectus | May 21, 2026 | — |
| 15F-12B | Filing | May 21, 2026 | — |
| 25 | Filing | May 11, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 11, 2026 | — |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| 6-K | Current report (foreign issuer) | May 1, 2026 | May 1, 2026 |
| 3 | Initial insider ownership | Apr 30, 2026 | Apr 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2026 | — |
| 20-F | Annual report (foreign issuer) | Apr 29, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Apr 29, 2026 | Apr 29, 2026 |
| 6-K | Current report (foreign issuer) | Apr 29, 2026 | Apr 29, 2026 |
| 6-K | Current report (foreign issuer) | Dec 18, 2025 | Dec 18, 2025 |
| 6-K | Current report (foreign issuer) | Dec 10, 2025 | Dec 10, 2025 |
| 6-K | Current report (foreign issuer) | Aug 28, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 11, 2025 | — |
| 6-K | Current report (foreign issuer) | Jul 16, 2025 | Jul 16, 2025 |
| 6-K | Current report (foreign issuer) | Jul 8, 2025 | Jul 8, 2025 |
| 6-K | Current report (foreign issuer) | Jun 16, 2025 | Jun 16, 2025 |
| 20-F | Annual report (foreign issuer) | Apr 30, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Apr 30, 2025 | Apr 30, 2025 |
| 6-K | Current report (foreign issuer) | Apr 7, 2025 | Apr 7, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 16, 2024 | Dec 16, 2024 |
| UPLOAD | Letter from the SEC | Nov 18, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 7, 2024 | — |
| 6-K | Current report (foreign issuer) | Oct 21, 2024 | Oct 21, 2024 |
| CORRESP | Letter to the SEC | Oct 11, 2024 | — |
| 6-K | Current report (foreign issuer) | Sep 27, 2024 | Sep 27, 2024 |
| UPLOAD | Letter from the SEC | Sep 17, 2024 | — |
| 6-K | Current report (foreign issuer) | Aug 28, 2024 | Aug 28, 2024 |
| 6-K | Current report (foreign issuer) | Aug 28, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Aug 22, 2024 | Aug 22, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jul 9, 2024 | — |
| 4 | Insider transaction | Jul 8, 2024 | Jul 2, 2024 |
| 6-K | Current report (foreign issuer) | Jun 24, 2024 | Jun 24, 2024 |
| SC TO-I/A | Filing | Jun 24, 2024 | — |
| 6-K | Current report (foreign issuer) | Jun 20, 2024 | Jun 20, 2024 |
| 6-K | Current report (foreign issuer) | Jun 13, 2024 | Jun 13, 2024 |
| SC TO-I/A | Filing | Jun 6, 2024 | — |
| 6-K | Current report (foreign issuer) | Jun 6, 2024 | Jun 6, 2024 |
| 6-K | Current report (foreign issuer) | Jun 4, 2024 | Jun 4, 2024 |
| CORRESP | Letter to the SEC | Jun 4, 2024 | — |
| SC TO-I/A | Filing | Jun 4, 2024 | — |
| UPLOAD | Letter from the SEC | May 30, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | May 30, 2024 | — |
| 6-K | Current report (foreign issuer) | May 29, 2024 | May 29, 2024 |
| 6-K | Current report (foreign issuer) | May 20, 2024 | May 20, 2024 |
| SC TO-I | Filing | May 20, 2024 | — |
| 20-F | Annual report (foreign issuer) | Apr 25, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Apr 25, 2024 | Apr 25, 2024 |
| 6-K | Current report (foreign issuer) | Apr 9, 2024 | Apr 9, 2024 |
| SC TO-C | Filing | Mar 19, 2024 | — |
| 6-K | Current report (foreign issuer) | Mar 19, 2024 | Mar 19, 2024 |
| 6-K | Current report (foreign issuer) | Mar 18, 2024 | Mar 18, 2024 |
| 6-K | Current report (foreign issuer) | Mar 4, 2024 | Feb 29, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| 6-K | Current report (foreign issuer) | Feb 5, 2024 | Jan 31, 2024 |
| 6-K | Current report (foreign issuer) | Jan 4, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Dec 20, 2023 | Dec 20, 2023 |
| 6-K | Current report (foreign issuer) | Dec 5, 2023 | Dec 5, 2023 |
| 6-K | Current report (foreign issuer) | Nov 2, 2023 | Nov 2, 2023 |
| 6-K | Current report (foreign issuer) | Oct 3, 2023 | Oct 3, 2023 |
| 4 | Insider transaction | Sep 21, 2023 | Sep 20, 2023 |
| 6-K | Current report (foreign issuer) | Sep 6, 2023 | Sep 6, 2023 |
| 6-K | Current report (foreign issuer) | Aug 29, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Aug 2, 2023 | Aug 2, 2023 |
| 6-K | Current report (foreign issuer) | Jul 6, 2023 | Jul 6, 2023 |
| 6-K | Current report (foreign issuer) | Jun 14, 2023 | Jun 13, 2023 |
| 4 | Insider transaction | Jun 14, 2023 | Jun 12, 2023 |
| 6-K | Current report (foreign issuer) | Jun 12, 2023 | Jun 12, 2023 |
| 6-K | Current report (foreign issuer) | Jun 2, 2023 | Jun 2, 2023 |
| 4 | Insider transaction | May 31, 2023 | May 26, 2023 |
| 6-K | Current report (foreign issuer) | May 3, 2023 | May 3, 2023 |
| 4 | Insider transaction | May 3, 2023 | May 1, 2023 |
| 20-F | Annual report (foreign issuer) | Apr 28, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Apr 28, 2023 | Apr 28, 2023 |
| 6-K | Current report (foreign issuer) | Apr 4, 2023 | Apr 4, 2023 |
| 6-K | Current report (foreign issuer) | Mar 23, 2023 | Mar 23, 2023 |
| 6-K | Current report (foreign issuer) | Mar 20, 2023 | Mar 20, 2023 |
| 6-K | Current report (foreign issuer) | Mar 2, 2023 | Mar 2, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| 6-K | Current report (foreign issuer) | Feb 3, 2023 | Jan 31, 2023 |
| 6-K | Current report (foreign issuer) | Dec 22, 2022 | Dec 22, 2022 |
| 6-K | Current report (foreign issuer) | Dec 2, 2022 | Nov 30, 2022 |
| 6-K | Current report (foreign issuer) | Nov 10, 2022 | Nov 10, 2022 |
| 6-K | Current report (foreign issuer) | Nov 3, 2022 | Nov 3, 2022 |
| 6-K | Current report (foreign issuer) | Oct 11, 2022 | Oct 11, 2022 |
| 6-K | Current report (foreign issuer) | Oct 7, 2022 | Oct 7, 2022 |
| 6-K | Current report (foreign issuer) | Oct 4, 2022 | Sep 30, 2022 |
| 6-K | Current report (foreign issuer) | Sep 2, 2022 | Aug 31, 2022 |
| SC 13D | Ownership over 5% (active) | Aug 30, 2022 | — |
| 3 | Initial insider ownership | Aug 29, 2022 | Aug 19, 2022 |
| 6-K | Current report (foreign issuer) | Aug 25, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Aug 22, 2022 | Aug 22, 2022 |
| 6-K | Current report (foreign issuer) | Aug 9, 2022 | Aug 9, 2022 |
| 6-K | Current report (foreign issuer) | Aug 4, 2022 | Jul 31, 2022 |
| 6-K | Current report (foreign issuer) | Jul 5, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Jun 15, 2022 | Jun 15, 2022 |
| 6-K | Current report (foreign issuer) | Jun 3, 2022 | Jun 3, 2022 |
| 6-K | Current report (foreign issuer) | May 9, 2022 | May 9, 2022 |
| 6-K | Current report (foreign issuer) | May 5, 2022 | May 5, 2022 |
| 20-F | Annual report (foreign issuer) | Apr 26, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Apr 26, 2022 | Apr 26, 2022 |
| 6-K | Current report (foreign issuer) | Mar 24, 2022 | Mar 24, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| 6-K | Current report (foreign issuer) | Jan 26, 2022 | Jan 26, 2022 |
| 3 | Initial insider ownership | Jan 21, 2022 | Jan 13, 2022 |
| 6-K | Current report (foreign issuer) | Jan 14, 2022 | Jan 14, 2022 |
| 6-K | Current report (foreign issuer) | Nov 10, 2021 | Nov 10, 2021 |
| 6-K | Current report (foreign issuer) | Nov 9, 2021 | Nov 9, 2021 |
| 6-K | Current report (foreign issuer) | Oct 12, 2021 | Oct 12, 2021 |
| 6-K | Current report (foreign issuer) | Aug 24, 2021 | Jun 30, 2021 |
| 6-K | Current report (foreign issuer) | Jul 19, 2021 | Jul 19, 2021 |
| 6-K | Current report (foreign issuer) | May 27, 2021 | May 27, 2021 |
| 20-F | Annual report (foreign issuer) | Apr 15, 2021 | Dec 31, 2020 |
| 6-K | Current report (foreign issuer) | Mar 18, 2021 | Mar 18, 2021 |
| 6-K | Current report (foreign issuer) | Mar 15, 2021 | Mar 15, 2021 |
| SC 13G | Ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13D/A | Amended ownership over 5% (active) | Feb 10, 2021 | — |
| 6-K | Current report (foreign issuer) | Feb 10, 2021 | Feb 10, 2021 |
| 6-K | Current report (foreign issuer) | Feb 5, 2021 | Feb 5, 2021 |
| 6-K | Current report (foreign issuer) | Jan 29, 2021 | Jan 29, 2021 |
| CERT | Filing | Nov 13, 2020 | — |
| EFFECT | Filing | Nov 12, 2020 | — |
| SEC STAFF ACTION | Filing | Nov 12, 2020 | — |
| SEC STAFF LETTER | Filing | Nov 12, 2020 | — |
| SEC STAFF LETTER | Filing | Nov 12, 2020 | — |
| 20FR12B/A | Filing | Nov 9, 2020 | — |
| F-6 | Filing | Nov 2, 2020 | — |
| 20FR12B | Filing | Oct 27, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 7, 2020 | — |
| DRS | Filing | Sep 22, 2020 | — |
Showing 134 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PTCHF (OTC), PRTCY (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- Boston, MA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1782999
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.